NCT03785418View on ClinicalTrials.gov

Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LIFE-AF)

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 29, 2018

Primary Completion Date

July 31, 2020

Study Completion Date

July 31, 2020

Conditions
Atrial Fibrillation
Interventions
BEHAVIORAL

Multicomponent Risk Factor Modification

Healthy eating, regular exercise and behavioural therapy.

Trial Locations (1)

K7L2V7

RECRUITING

Kingston Health Sciences Centre, Kingston

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

University of Toronto

OTHER

lead

Dr. Benedict Glover

OTHER

NCT03785418 - Lifestyle Modification for the Treatment of Symptomatic Atrial Fibrillation (LIFE-AF) | Biotech Hunter | Biotech Hunter